Catalyst Wire Dossier Catalyst Wire Dossier

IRL201104

· Revolo Biotherapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IRL201104, covering 2023-05-03 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis [Phase 2]

See pricing